Keep your healthcare team informed of any persistent or worsening skin changes, as they can assess whether these require investigation or modification of your treatment plan
Carmot is currently conducting a multi-center, randomized, placebo-controlled Phase 2 clinical trial of CT-868 in participants with overweight/obesity and T1D to assess efficacy, safety, tolerability, and pharmacokinetics
When tirzepatide expires, its effectiveness diminishes, and in some cases, it can become potentially harmful
What Does A Normal Reaction Look Like Versus A Dangerous One
Roe reports that the average respondent decreased daily calorie intake by nearly 700 calories compared to pre-medication intake levels
This has the potential to help the body utilize nutrients effectively and could bolster the efficacy of treatment